Gastroparesis Market Growth Steady at 4 3% CAGR to Reach $6,025. 11 Million by 2027: COVID-19 Impact and Global Analysis by The Insight Partners

Published Apr 08 2021 at 11:30 AM GMT
  • Pune, India, April 08, 2021 (GLOBE NEWSWIRE) -- According to our new research study on "Gastroparesis Market to 2027 " Global Analysis and Forecast " by Gastroparesis Type, Drug Class Type, and Distribution Channel," the Gastroparesis Market was valued at US$ 4,338.61 million in 2019 and is projected to reach US$ 6,025.
  • 11 million by 2027; it is expected to grow at a CAGR of 4 3% during 2020"2027.
  • Gastroparesis Market: Key InsightsIn 2019, North America dominated the global gastroparesis market and accounted for approximately half of the market revenue.
  • The market growth in North America is credited to the increasing prevalence of diabetes, rising number of abdominal surgical procedures performed every year, and focus on development of innovative drug delivery technologies.
  • The COVID-19 pandemic and mitigation measures have harmed global economic conditions.


  • Published Apr 8, 2021 11:30 AM GMT